Root Financial Partners
ADMA icon

Root Financial Partners’s ADMA Biologics ADMA Stock Holding History

Root Financial Partners’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.8K Buy
+479
New +$4.43K ﹤0.01% 2246
2026
Q2 		– Sell
-440
Closed -$3.96K – 450
2026
Q1 		$3.96K Buy
440
+61
+16% +$963 ﹤0.01% 2041
2025
Q4 		$6.91K Buy
379
+113
+42% +$1.9K ﹤0.01% 1652
2025
Q3 		$3.9K Buy
+266
New +$4.56K ﹤0.01% 1804

Other funds holding ADMA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Root Financial Partners's ADMA Position: Q3 2026 in Review

Root Financial Partners opened a new position in ADMA Biologics (ADMA) in Q3 2026: 479 shares worth $4.8K. The stake represents ﹤0.01% of the portfolio and ranks #2246 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in ADMA as recently as Q1 2026.

Root Financial Partners first reported a position in ADMA in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.91K in Q4 2025. 262 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • Root Financial Partners held 479 shares of ADMA Biologics worth $4.8K as of Q3 2026.
  • ADMA Biologics was a new Root Financial Partners position in Q3 2026.
  • ADMA Biologics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2246 holding.
  • Root Financial Partners first reported a position in ADMA Biologics in Q3 2025 and has held it in 4 quarters since.
  • Root Financial Partners's ADMA Biologics position peaked at $6.91K in Q4 2025.
  • 262 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.